ASX - By Stock
|
AVR |
Re:
First VIV in Europe! Great outcome.
|
|
fireboss
|
35 |
11K |
7 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
35
|
11K
|
7
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Capital Raise
|
|
fireboss
|
20 |
8.1K |
0 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
20
|
8.1K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Change of Director's Interest Notice
|
|
fireboss
|
13 |
3.5K |
1 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
13
|
3.5K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: 30-day Haemodynamic Results from the DurAVR US EFS Trial
|
|
fireboss
|
74 |
24K |
1 |
24/11/23 |
24/11/23 |
ASX - By Stock
|
74
|
24K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: 30-day Haemodynamic Results from the DurAVR US EFS Trial
|
|
fireboss
|
74 |
24K |
12 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
74
|
24K
|
12
|
|
ASX - By Stock
|
AVR |
Re:
London Valves news and mentions
|
|
fireboss
|
6 |
2.0K |
22 |
21/11/23 |
21/11/23 |
ASX - By Stock
|
6
|
2.0K
|
22
|
|
ASX - By Stock
|
AVR |
Re:
TAVR MARKET Superiority
|
|
fireboss
|
87 |
30K |
12 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
87
|
30K
|
12
|
|
ASX - By Stock
|
AVR |
Re:
Results presented at TCT
|
|
fireboss
|
13 |
4.5K |
31 |
25/10/23 |
25/10/23 |
ASX - By Stock
|
13
|
4.5K
|
31
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Trading Halt
|
|
fireboss
|
40 |
13K |
2 |
24/10/23 |
24/10/23 |
ASX - By Stock
|
40
|
13K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
A nice update to our website. Check out the whole page for times and dates of TVT pressos.
|
|
fireboss
|
1 |
1.1K |
16 |
24/10/23 |
24/10/23 |
ASX - By Stock
|
1
|
1.1K
|
16
|
|
ASX - By Stock
|
AVR |
Re:
For those who are interested
|
|
fireboss
|
11 |
4.6K |
3 |
24/08/23 |
24/08/23 |
ASX - By Stock
|
11
|
4.6K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
For those who are interested
|
|
fireboss
|
11 |
4.6K |
16 |
24/08/23 |
24/08/23 |
ASX - By Stock
|
11
|
4.6K
|
16
|
|
ASX - By Stock
|
AVR |
Re:
For those who are interested
|
|
fireboss
|
11 |
4.6K |
4 |
24/08/23 |
24/08/23 |
ASX - By Stock
|
11
|
4.6K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Exceptional Results in Second Valve-in-Valve Case
|
|
fireboss
|
42 |
13K |
16 |
16/08/23 |
16/08/23 |
ASX - By Stock
|
42
|
13K
|
16
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Montefiore enrolls Patients in US Early Feasibility Study
|
|
fireboss
|
28 |
8.2K |
9 |
09/08/23 |
09/08/23 |
ASX - By Stock
|
28
|
8.2K
|
9
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Montefiore enrolls Patients in US Early Feasibility Study
|
|
fireboss
|
28 |
8.2K |
4 |
09/08/23 |
09/08/23 |
ASX - By Stock
|
28
|
8.2K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
Ann: DurAVR Maintains Exceptional Results in New Patient Cohort
|
|
fireboss
|
35 |
14K |
1 |
12/06/23 |
12/06/23 |
ASX - By Stock
|
35
|
14K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
AGM recording
|
|
fireboss
|
19 |
6.5K |
3 |
01/06/23 |
01/06/23 |
ASX - By Stock
|
19
|
6.5K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
AGM questions for submission to management
|
|
fireboss
|
37 |
15K |
0 |
26/05/23 |
26/05/23 |
ASX - By Stock
|
37
|
15K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
AGM questions for submission to management
|
|
fireboss
|
37 |
15K |
7 |
23/05/23 |
23/05/23 |
ASX - By Stock
|
37
|
15K
|
7
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Trading Halt
|
|
fireboss
|
78 |
26K |
0 |
06/02/23 |
06/02/23 |
ASX - By Stock
|
78
|
26K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Trading Halt
|
|
fireboss
|
78 |
26K |
0 |
06/02/23 |
06/02/23 |
ASX - By Stock
|
78
|
26K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
fireboss
|
26 |
9.5K |
2 |
03/02/23 |
03/02/23 |
ASX - By Stock
|
26
|
9.5K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Trading Halt
|
|
fireboss
|
78 |
26K |
0 |
02/02/23 |
02/02/23 |
ASX - By Stock
|
78
|
26K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
fireboss
|
26 |
9.5K |
3 |
02/02/23 |
02/02/23 |
ASX - By Stock
|
26
|
9.5K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
fireboss
|
26 |
9.5K |
22 |
02/02/23 |
02/02/23 |
ASX - By Stock
|
26
|
9.5K
|
22
|
|
ASX - By Stock
|
AVR |
Re:
AVR milestones
|
|
fireboss
|
74 |
32K |
2 |
16/01/23 |
16/01/23 |
ASX - By Stock
|
74
|
32K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
AVR milestones
|
|
fireboss
|
74 |
32K |
20 |
22/12/22 |
22/12/22 |
ASX - By Stock
|
74
|
32K
|
20
|
|
ASX - By Stock
|
AVR |
Re:
New research report from Evolution Capital
|
|
fireboss
|
38 |
13K |
7 |
01/12/22 |
01/12/22 |
ASX - By Stock
|
38
|
13K
|
7
|
|
ASX - By Stock
|
AVR |
Re:
Ann: FDA Approves Early Feasibility Study for DurAVR THV System
|
|
fireboss
|
47 |
18K |
12 |
28/11/22 |
28/11/22 |
ASX - By Stock
|
47
|
18K
|
12
|
|
ASX - By Stock
|
AVR |
Re:
Ann: FDA Approves Early Feasibility Study for DurAVR THV System
|
|
fireboss
|
47 |
18K |
16 |
28/11/22 |
28/11/22 |
ASX - By Stock
|
47
|
18K
|
16
|
|
ASX - By Stock
|
AVR |
Re:
Talking about TAVR on Sky News this morning In Uk
|
|
fireboss
|
29 |
12K |
15 |
02/11/22 |
02/11/22 |
ASX - By Stock
|
29
|
12K
|
15
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Notification of cessation of securities - AVR
|
|
fireboss
|
16 |
5.9K |
1 |
08/08/22 |
08/08/22 |
ASX - By Stock
|
16
|
5.9K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Third Conversion of Securities - Mercer
|
|
fireboss
|
43 |
18K |
1 |
04/08/22 |
04/08/22 |
ASX - By Stock
|
43
|
18K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Update on First In Human DurAVR THV Study
|
|
fireboss
|
41 |
14K |
13 |
11/07/22 |
11/07/22 |
ASX - By Stock
|
41
|
14K
|
13
|
|
ASX - By Stock
|
AVR |
Re:
Ann: DurAVR First In Human Patient 6 Month Study Follow Up
|
|
fireboss
|
71 |
22K |
0 |
23/06/22 |
23/06/22 |
ASX - By Stock
|
71
|
22K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Second Conversion of Securities - Mercer
|
|
fireboss
|
8 |
3.8K |
3 |
01/06/22 |
01/06/22 |
ASX - By Stock
|
8
|
3.8K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Second Conversion of Securities - Mercer
|
|
fireboss
|
8 |
3.8K |
7 |
01/06/22 |
01/06/22 |
ASX - By Stock
|
8
|
3.8K
|
7
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Successful Completion of Second First-In-Human Study
|
|
fireboss
|
20 |
9.7K |
12 |
01/06/22 |
01/06/22 |
ASX - By Stock
|
20
|
9.7K
|
12
|
|
ASX - By Stock
|
AVR |
Re:
AVR CMO Dr Chris Meduri discusses DurAVR with Dr Bapat
|
|
fireboss
|
16 |
6.1K |
1 |
24/05/22 |
24/05/22 |
ASX - By Stock
|
16
|
6.1K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: USD 20M Placement - Perceptive Advisors
|
|
fireboss
|
21 |
8.0K |
3 |
02/03/22 |
02/03/22 |
ASX - By Stock
|
21
|
8.0K
|
3
|
|
ASX - By Stock
|
AVR |
Medtronic's "Evolut Pro" vs Edwards "Sapien 3" trail now enrollling
|
|
fireboss
|
0 |
434 |
12 |
10/02/22 |
10/02/22 |
ASX - By Stock
|
0
|
434
|
12
|
|
ASX - By Stock
|
AVR |
Re:
News: AVR Anteris Technologies Says Co Has Received A Confidential, Non-Binding Proposal To...
|
|
fireboss
|
57 |
15K |
0 |
08/02/22 |
08/02/22 |
ASX - By Stock
|
57
|
15K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
News: AVR Anteris Technologies Says Co Has Received A Confidential, Non-Binding Proposal To...
|
|
fireboss
|
57 |
15K |
6 |
08/02/22 |
08/02/22 |
ASX - By Stock
|
57
|
15K
|
6
|
|
ASX - By Stock
|
AVR |
Re:
News: AVR Anteris Technologies Says Co Has Received A Confidential, Non-Binding Proposal To...
|
|
fireboss
|
57 |
15K |
2 |
08/02/22 |
08/02/22 |
ASX - By Stock
|
57
|
15K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
News: AVR Anteris Technologies Says Co Has Received A Confidential, Non-Binding Proposal To...
|
|
fireboss
|
57 |
15K |
2 |
08/02/22 |
08/02/22 |
ASX - By Stock
|
57
|
15K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
News: AVR Anteris Technologies Says Co Has Received A Confidential, Non-Binding Proposal To...
|
|
fireboss
|
57 |
15K |
1 |
08/02/22 |
08/02/22 |
ASX - By Stock
|
57
|
15K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
News: AVR Anteris Technologies Says Co Has Received A Confidential, Non-Binding Proposal To...
|
|
fireboss
|
57 |
15K |
3 |
08/02/22 |
08/02/22 |
ASX - By Stock
|
57
|
15K
|
3
|
|
ASX - By Stock
|
BRN |
Re:
Intentionally Misleading Article Pinned to Top of Hotcopper
|
|
fireboss
|
146 |
44K |
7 |
04/02/22 |
04/02/22 |
ASX - By Stock
|
146
|
44K
|
7
|
|
ASX - By Stock
|
BRN |
Re:
Be aware The Market Herald owns HotCopper
|
|
fireboss
|
120 |
33K |
24 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
120
|
33K
|
24
|
|